‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents
THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking s...
Gespeichert in:
Veröffentlicht in: | Nature (London) 1959-02, Vol.183 (4658), p.399-400 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 400 |
---|---|
container_issue | 4658 |
container_start_page | 399 |
container_title | Nature (London) |
container_volume | 183 |
creator | BARDOS, THOMAS J. PAPANASTASSIOU, ZINON B. SEGALOFF, ALBERT AMBRUS, JULIAN L. |
description | THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences. |
doi_str_mv | 10.1038/183399a0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_82293953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>82293953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</originalsourceid><addsrcrecordid>eNplkM1OwkAUhSdGI4gmPoHpysBidP7aacOK4G9CcCGum2l7C8VpB2faGHY8hr4eT2IJGBcubs7ifvmScxC6pOSGEh7e0pDzKFLkCHWpkAEWQSiPUZcQFmIS8qCDzpxbEkJ8KsUp6lAecCZ50EV6u_m6a5T2RlWt5qYqXO22m--hN9Lva-1NcT8pHO5DvVhrqIqyyMxgtTCuPWsGOFU2UaWqwQ095U3h03sFW4DzTL4zFnjWlKax3mgOVe3O0UmutIOLQ_bQ28P9bPyEJy-Pz-PRBKec-jXOEuZTESUUhJ_6IfVVJgnliqpcCAEilAHPpEyziAUsSJjMkohLkEQInlOa8B663ntX1nw04Oq4LFwKWqsKTOPikLGIRz5vwf4eTK1xzkIer2xRKruOKYl3y8a_y7bo1cHZJCVkf-BhyhYY7AHXvqo52HjZNq_anv9lP6CCgRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>82293953</pqid></control><display><type>article</type><title>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</title><source>MEDLINE</source><source>Nature</source><source>Springer Nature - Complete Springer Journals</source><creator>BARDOS, THOMAS J. ; PAPANASTASSIOU, ZINON B. ; SEGALOFF, ALBERT ; AMBRUS, JULIAN L.</creator><creatorcontrib>BARDOS, THOMAS J. ; PAPANASTASSIOU, ZINON B. ; SEGALOFF, ALBERT ; AMBRUS, JULIAN L.</creatorcontrib><description>THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences.</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/183399a0</identifier><identifier>PMID: 13632736</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Antineoplastic Agents ; Carbamates ; Esters ; Humanities and Social Sciences ; Humans ; letter ; multidisciplinary ; Neoplasms ; Old Medline ; Science ; Science (multidisciplinary)</subject><ispartof>Nature (London), 1959-02, Vol.183 (4658), p.399-400</ispartof><rights>Springer Nature Limited 1959</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</citedby><cites>FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/183399a0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/183399a0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/13632736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BARDOS, THOMAS J.</creatorcontrib><creatorcontrib>PAPANASTASSIOU, ZINON B.</creatorcontrib><creatorcontrib>SEGALOFF, ALBERT</creatorcontrib><creatorcontrib>AMBRUS, JULIAN L.</creatorcontrib><title>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</title><title>Nature (London)</title><addtitle>Nature</addtitle><addtitle>Nature</addtitle><description>THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences.</description><subject>Antineoplastic Agents</subject><subject>Carbamates</subject><subject>Esters</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>letter</subject><subject>multidisciplinary</subject><subject>Neoplasms</subject><subject>Old Medline</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1959</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkM1OwkAUhSdGI4gmPoHpysBidP7aacOK4G9CcCGum2l7C8VpB2faGHY8hr4eT2IJGBcubs7ifvmScxC6pOSGEh7e0pDzKFLkCHWpkAEWQSiPUZcQFmIS8qCDzpxbEkJ8KsUp6lAecCZ50EV6u_m6a5T2RlWt5qYqXO22m--hN9Lva-1NcT8pHO5DvVhrqIqyyMxgtTCuPWsGOFU2UaWqwQ095U3h03sFW4DzTL4zFnjWlKax3mgOVe3O0UmutIOLQ_bQ28P9bPyEJy-Pz-PRBKec-jXOEuZTESUUhJ_6IfVVJgnliqpcCAEilAHPpEyziAUsSJjMkohLkEQInlOa8B663ntX1nw04Oq4LFwKWqsKTOPikLGIRz5vwf4eTK1xzkIer2xRKruOKYl3y8a_y7bo1cHZJCVkf-BhyhYY7AHXvqo52HjZNq_anv9lP6CCgRA</recordid><startdate>19590207</startdate><enddate>19590207</enddate><creator>BARDOS, THOMAS J.</creator><creator>PAPANASTASSIOU, ZINON B.</creator><creator>SEGALOFF, ALBERT</creator><creator>AMBRUS, JULIAN L.</creator><general>Nature Publishing Group UK</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19590207</creationdate><title>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</title><author>BARDOS, THOMAS J. ; PAPANASTASSIOU, ZINON B. ; SEGALOFF, ALBERT ; AMBRUS, JULIAN L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c315t-db25149b1e45c5815ad7013a1af444e48763d77cd92626b27db937e70443f11b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1959</creationdate><topic>Antineoplastic Agents</topic><topic>Carbamates</topic><topic>Esters</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>letter</topic><topic>multidisciplinary</topic><topic>Neoplasms</topic><topic>Old Medline</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BARDOS, THOMAS J.</creatorcontrib><creatorcontrib>PAPANASTASSIOU, ZINON B.</creatorcontrib><creatorcontrib>SEGALOFF, ALBERT</creatorcontrib><creatorcontrib>AMBRUS, JULIAN L.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BARDOS, THOMAS J.</au><au>PAPANASTASSIOU, ZINON B.</au><au>SEGALOFF, ALBERT</au><au>AMBRUS, JULIAN L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents</atitle><jtitle>Nature (London)</jtitle><stitle>Nature</stitle><addtitle>Nature</addtitle><date>1959-02-07</date><risdate>1959</risdate><volume>183</volume><issue>4658</issue><spage>399</spage><epage>400</epage><pages>399-400</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><abstract>THE concept of combination chemotherapy in the treatment of neoplastic diseases has been receiving considerable attention during the past few years. Some see the only theoretically possible solution to the problem of cancer chemotherapy in the simultaneous use of several synergistic drugs blocking several consecutive and/or alternative metabolic pathways, while others vigorously object to this thesis, from practical considerations or disappointing experiences.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>13632736</pmid><doi>10.1038/183399a0</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-0836 |
ispartof | Nature (London), 1959-02, Vol.183 (4658), p.399-400 |
issn | 0028-0836 1476-4687 |
language | eng |
recordid | cdi_proquest_miscellaneous_82293953 |
source | MEDLINE; Nature; Springer Nature - Complete Springer Journals |
subjects | Antineoplastic Agents Carbamates Esters Humanities and Social Sciences Humans letter multidisciplinary Neoplasms Old Medline Science Science (multidisciplinary) |
title | ‘Dual Antagonists’; Alkyl N-(bis-(ethylenimido)phosphoro)-carbamates; a New Series of Anti-Tumour Agents |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A21%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%98Dual%20Antagonists%E2%80%99;%20Alkyl%20N-(bis-(ethylenimido)phosphoro)-carbamates;%20a%20New%20Series%20of%20Anti-Tumour%20Agents&rft.jtitle=Nature%20(London)&rft.au=BARDOS,%20THOMAS%20J.&rft.date=1959-02-07&rft.volume=183&rft.issue=4658&rft.spage=399&rft.epage=400&rft.pages=399-400&rft.issn=0028-0836&rft.eissn=1476-4687&rft_id=info:doi/10.1038/183399a0&rft_dat=%3Cproquest_cross%3E82293953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=82293953&rft_id=info:pmid/13632736&rfr_iscdi=true |